213 related articles for article (PubMed ID: 35392074)
1. Efficacy and Safety of BCG Revaccination With
Dos Anjos LRB; da Costa AC; Cardoso ADRO; Guimarães RA; Rodrigues RL; Ribeiro KM; Borges KCM; Carvalho ACO; Dias CIS; Rezende AO; Souza CC; Ferreira RRM; Saraiva G; Barbosa LCS; Vieira TDS; Conte MB; Rabahi MF; Kipnis A; Junqueira-Kipnis AP
Front Immunol; 2022; 13():841868. PubMed ID: 35392074
[TBL] [Abstract][Full Text] [Related]
2. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
[TBL] [Abstract][Full Text] [Related]
3. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
4. Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials.
Ten Doesschate T; Moorlag SJCFM; van der Vaart TW; Taks E; Debisarun P; Ten Oever J; Bleeker-Rovers CP; Verhagen PB; Lalmohamed A; Ter Heine R; van Crevel R; van de Wijgert J; Janssen AB; Bonten MJ; van Werkhoven CH; Netea MG;
Trials; 2020 Jun; 21(1):481. PubMed ID: 32503602
[TBL] [Abstract][Full Text] [Related]
5. Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial.
Ten Doesschate T; van der Vaart TW; Debisarun PA; Taks E; Moorlag SJCFM; Paternotte N; Boersma WG; Kuiper VP; Roukens AHE; Rijnders BJA; Voss A; Veerman KM; Kerckhoffs APM; Oever JT; van Crevel R; van Nieuwkoop C; Lalmohamed A; van de Wijgert JHHM; Netea MG; Bonten MJM; van Werkhoven CH
Clin Microbiol Infect; 2022 Sep; 28(9):1278-1285. PubMed ID: 35489606
[TBL] [Abstract][Full Text] [Related]
6. Using BCG Vaccine to Enhance Nonspecific Protection of Health Care Workers During the COVID-19 Pandemic: A Randomized Controlled Trial.
Madsen AMR; Schaltz-Buchholzer F; Nielsen S; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Azizi M; Hameed ZN; Johansen IS; Kofoed PE; Krause TG; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Oedegaard ES; Ostenfeld A; Soerensen MK; Wejse C; Netea MG; Aaby P; Benn CS
J Infect Dis; 2024 Feb; 229(2):384-393. PubMed ID: 37774494
[TBL] [Abstract][Full Text] [Related]
7. Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses.
Suliman S; Geldenhuys H; Johnson JL; Hughes JE; Smit E; Murphy M; Toefy A; Lerumo L; Hopley C; Pienaar B; Chheng P; Nemes E; Hoft DF; Hanekom WA; Boom WH; Hatherill M; Scriba TJ
J Immunol; 2016 Aug; 197(4):1100-1110. PubMed ID: 27412415
[TBL] [Abstract][Full Text] [Related]
8. Systematic review protocol on Bacillus Calmette-Guerin (BCG) revaccination and protection against tuberculosis.
Mahasha PW; Ndwandwe DE; Mavundza EJ; Shey M; Wiysonge CS
BMJ Open; 2019 Oct; 9(10):e027033. PubMed ID: 31619416
[TBL] [Abstract][Full Text] [Related]
9. The effect of BCG vaccination on infection and antibody levels against SARS-CoV-2-The results of ProBCG: a multicenter randomized clinical trial in Brazil.
Santos AP; Werneck GL; Dalvi APR; Dos Santos CC; Tierno PFGMM; Condelo HS; Macedo B; de Medeiros Leung JA; de Souza Nogueira J; Malvão L; Galliez R; Aguiar R; Stefan R; Knackfuss SM; da Silva EC; Castineiras TMPP; de Andrade Medronho R; E Silva JRL; Alves RLR; de Moraes Sobrino Porto LC; Rodrigues LS; Kritski AL; de Queiroz Mello FC
Int J Infect Dis; 2023 May; 130():8-16. PubMed ID: 36841502
[TBL] [Abstract][Full Text] [Related]
10. Neonatal revaccination with Bacillus Calmette-Guérin elicits improved, early protection against Mycobacterium tuberculosis in mice.
Li W; Huang H; Hua W; Ben S; Liu H; Xu B; Xian Q; Tang Z; Shen H
Vaccine; 2012 May; 30(21):3223-30. PubMed ID: 22342709
[TBL] [Abstract][Full Text] [Related]
11. The safety of BCG revaccination: A systematic review.
Bannister S; Sudbury E; Villanueva P; Perrett K; Curtis N
Vaccine; 2021 May; 39(20):2736-2745. PubMed ID: 33810902
[TBL] [Abstract][Full Text] [Related]
12. Bacillus Calmette-Guérin revaccination questionable with low tuberculosis incidence.
Tala-Heikkilä MM; Tuominen JE; Tala EO
Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1324-7. PubMed ID: 9563757
[TBL] [Abstract][Full Text] [Related]
13. The safety of BCG revaccination in the context of COVID-19.
Sánchez-García A; Támez-Guerra R; González-Saldivar G; Rodríguez-Gutiérrez R; Ramírez-García LA; Barrera FJ; González-González JG
Hum Vaccin Immunother; 2023 Dec; 19(3):2271760. PubMed ID: 37936434
[TBL] [Abstract][Full Text] [Related]
14. The Relationship between COVID-19 Severity and Bacillus Calmette-Guérin (BCG)/
Torun S; Ozkaya S; Şen N; Kanat F; Karaman I; Yosunkaya S; Sengoren Dikis O; Asan A; Aydogan Eroglu S; Semih Atal S; Ayten O; Aksel N; Ermiş H; Özçelik N; Demirelli M; Kara I; Sümer S; Marakoğlu K; Üzer F; Uyar Y; Çiçek T; E Ünsal Z; Vatansev H; Botan Yildirim B; Kuruoğlu T; Atilla A; Ersoy Y; Kandemir B; Durduran Y; Goksin Cihan F; Demirbaş N; Yıldırım F; Tatar D; Akcay MS
Pathog Glob Health; 2021 Sep; 115(6):405-411. PubMed ID: 34014806
[TBL] [Abstract][Full Text] [Related]
15. Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered.
Dye C
J R Soc Interface; 2013 Oct; 10(87):20130365. PubMed ID: 23904584
[TBL] [Abstract][Full Text] [Related]
16. Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.
Glisic S; Perovic VR; Sencanski M; Paessler S; Veljkovic V
J Proteome Res; 2020 Nov; 19(11):4649-4654. PubMed ID: 32794723
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Bacillus Calmette-Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial.
Sinha S; Ajayababu A; Thukral H; Gupta S; Guha SK; Basu A; Gupta G; Thakur P; Lingaiah R; Das BK; Singh UB; Singh R; Narang R; Bhowmik D; Wig N; Modak DC; Bandyopadhyay B; Chakrabarty B; Kapoor A; Tewari S; Prasad N; Hashim Z; Nath A; Kumari N; Goswami R; Pandey S; Pandey RM
Infect Dis Ther; 2022 Dec; 11(6):2205-2217. PubMed ID: 36242739
[TBL] [Abstract][Full Text] [Related]
18. Exploring the role of bacillus calmette-guerin vaccination in protection against COVID-19.
Chauhan A; Singh M; Agarwal A; Jaiswal N; M Lakshmi PV; Singh M
Int J Mycobacteriol; 2021; 10(4):433-436. PubMed ID: 34916464
[TBL] [Abstract][Full Text] [Related]
19. Revaccination with Bacillus Calmette-Guerin (BCG) vaccine does not reduce morbidity from malaria in African children.
Rodrigues A; Schellenberg JA; Roth A; Benn CS; Aaby P; Greenwood B
Trop Med Int Health; 2007 Feb; 12(2):224-9. PubMed ID: 17300629
[TBL] [Abstract][Full Text] [Related]
20. BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic?
Sharma AR; Batra G; Kumar M; Mishra A; Singla R; Singh A; Singh RS; Medhi B
Allergol Immunopathol (Madr); 2020; 48(5):507-517. PubMed ID: 32653224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
